Arimidex


Also found in: Medical.
Related to Arimidex: tamoxifen

Arimidex

(ˌærɪmɪˈdɛks)
n
(Pharmacology) a trade name for anastrozole
Mentioned in ?
References in periodicals archive ?
NASDAQ: ANIP) has acquired US rights to market AstraZeneca's NDAs ATACAND, ATACAND HCT, ARIMIDEX and CASODEX in a transaction valued at USD 46.
M2 EQUITYBITES-January 2, 2018-ANI Pharmaceuticals acquires NDAs and US marketing rights for ATACAND, ATACAND HCT, ARIMIDEX, and CASODEX
M2 PHARMA-January 2, 2018-ANI Pharmaceuticals acquires NDAs and US marketing rights for ATACAND, ATACAND HCT, ARIMIDEX, and CASODEX
The global breast cancer therapeutics market report estimates the market size (Revenue USD million - 2013 to 2020) for key market segments based on the drug classes - brand name (chemical name) such as antimetabolites - Gemzar (gemcitabine), aromatase inhibitors - Afinitor (everolimus), Arimidex (anastrozole), Aromasin (exemestane), Femara (leterozole), Ibrance (palbociclib); Her2 Inhibitors - Herceptin (trastuzumab), Kadcyla (ado-trastuzumab emtansine), Perjeta (pertuzumab), Tykerb (lapatinib); Hormone receptors - Fareston, Faslodex, Zoladex; and Mitotic inhibitors - Halaven (eribulin), Ixempra (ixabepilone), Taxotere (docetaxel), and forecasts growth trends (CAGR% - 2016 to 2020).
And drugs like Arimidex and Herceptin have improved survival rates.
The company has had several drug development setbacks with experimental depression and ovarian cancer drugs, as well as loss of exclusivity on several key brands, Seroquel IR, Nexium and Arimidex, escalating concerns about long-term strategy and prospects.
Astra's so-called "patent cliff" - when revenues drop off as patents expire - is particularly steep as breast cancer drug Arimidex has already lost patent protection, while acid reflux treatment Nexium and biggest seller Crestor will lose patent protection in the next four years.
Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.
Aromasin, AstraZeneca's Arimidex, and Femara from Novartis, are in a family of medicines known as aromatase inhibitors that work by halting production of estrogen, a hormone that fuels cancer growth.
Anastrozole remained superior to tamoxifen as an adjuvant treatment for invasive breast cancer in postmenopausal women, based on 10-year follow-up data from the Arimidex, Tamoxifen Alone or in Combination trial known as ATAC.
In the next paragraph, you can read about the side effects seen with Arimidex which include: "hot flashes, joint symptoms, weakness, mood changes, pain, sore throat, nausea and vomiting, depression, high blood pressure, osteoporosis (
Women with hormone-receptor-positive tumours who reported these symptoms at the first follow-up visit in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial were compared with those without these symptoms to see if there was a relationship between the symptoms and recurrence.